Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JanOne Board Approves Strategic Review Of Biotech Assets And ALT5 Sigma Being Core Focus Going Forward; Will Change Name To 'ALT5 Sigma Corporation' And Ticker to Change To 'ALTS'

Author: Bill Haddad | July 10, 2024 08:39am

Posted In: JAN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist